Health Trials

Squamous Non-small Cell Lung Cancer(NSCLC)

1

Review clinical trials related to Squamous Non-small Cell Lung Cancer(NSCLC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of HDM2020 in Patients With Advanced Sq-NSCLC

The goal of this clinical trial is to learn if the study drug can treat in advanced squamous non-small cell lung cancer(NSCLC) patients. The main questions it aims to answer are: Is the drug safe and tolerable? Does the drug show antitumor activity? Participants will receive the study drug once(D1) or twice(D1.D8) every three weeks, and undergo imaging-based efficacy assessments every six weeks.

Participants needed: 150
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Updated: Jun 10, 2026Locations: 1
Eligibility criteria

Participants who are able to understand and voluntarily sign a written Informed... [+9]

Participants with prior treatment with an ADC containing a topoisomerase I (Top... [+16]

Read more